Standout Papers
- Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial (2016)
- Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial (2016)
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma (2017)
- Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial (2021)
Immediate Impact
1 from Science/Nature 63 standout
Citing Papers
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2025 Standout
Works of Peter Barker being referenced
Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
2022
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Peter Barker | 2887 | 988 | 2274 | 47 | 4.1k | |
| Tore Persson | 1412 | 1504 | 1334 | 70 | 5.2k | |
| Ruth H. Green | 5399 | 801 | 4170 | 32 | 6.4k | |
| Ana R. Sousa | 4267 | 853 | 2504 | 74 | 5.7k | |
| Stephanie Korn | 5283 | 1087 | 4085 | 95 | 6.1k | |
| J.H.J.M. van Krieken | 827 | 1005 | 1312 | 34 | 3.4k | |
| Kevin McGrath | 826 | 1485 | 1244 | 97 | 3.1k | |
| Jean‐Pierre Grünfeld | 468 | 657 | 1463 | 142 | 7.2k | |
| A. H. Zwinderman | 1081 | 424 | 811 | 48 | 3.9k | |
| Brett M. Elicker | 1961 | 422 | 4784 | 94 | 6.2k | |
| Francesco Scolari | 353 | 634 | 1557 | 165 | 6.8k |
All Works
Loading papers...